Ebola Drug Made From Tobacco Plant Saves U.S. Aid Workers

 Aug 4, 2014

http://www.bloomberg.com/news/2014-08-05/ebola-drug-made-from-tobac...

Aug. 5 -- Bloomberg’s Yang Yang reports on U.S. Ebola patients treated with Zmapp experimental drug from Mapp Pharmaceuticals in San Diego. She speaks with Betty Liu on “In The Loop.” (Source: Bloomberg)

Related

A tiny San Diego-based company provided an experimental Ebola treatment for two Americans infected with the deadly virus in Liberia. The biotechnology drug, produced with tobacco plants, appears to be working.

In an unusual twist of expedited drug access, Mapp Biopharmaceutical Inc., which has nine employees, released its experimental ZMapp drug, until now only tested on infected animals, for the two health workers. Kentucky BioProcessing LLC, a subsidiary of tobacco giant Reynolds American Inc. (RAI), manufactures the treatment for Mapp from tobacco plants.

The first patient, Kent Brantly, a doctor, was flown from Liberia to Atlanta on Aug. 2, and is receiving treatment at Emory University Hospital. Nancy Writebol, an aid worker, is scheduled to arrive in Atlanta today and will be treated at the same hospital, according to the charity group she works with. Both are improving, according to relatives and supporters.

Each patient received at least one dose of ZMapp in Liberia before coming to the U.S., according to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

Related:

“There’s a very scarce number of doses,” and it’s not clear how many each patient needs for treatment, Fauci said. “I’m not sure how many doses they’ll get.”

Photographer: WSB-TV Atlanta/AP

An ambulance arrives with U.S. doctor Kent Brantly, right, at Emory University... Read More


Citing unnamed sources, CNN yesterday reported that the drug used for the treatment is Mapp’s.

Ebola Outbreak

Ebola, spread through direct contact with body fluids such as blood and urine, has sickened 1,603 people in West Africa, killing 887, according to the World Health Organization. The disease, first reported in what is now the Democratic Republic of Congo in 1976, can cause bleeding from the eyes, ears and nose.

The Deadliest Disease on Earth

The virus has historically killed as many as 90 percent of those who contract it. The current outbreak has a fatality rate of about 60 percent, probably because of early treatment efforts, officials have said.

There is no cure for Ebola, although several companies -- including Mapp -- are working on drug candidates that are undergoing animal testing. Normally, patients are given fluids, blood transfusions and antibiotics with the hope their immune systems can fight off Ebola’s onslaught.

The two scientists behind Mapp, President Larry Zeitlin and Chief Executive Officer Kevin Whaley, “are both brilliant,” said Charles Arntzen, a plant biotechnology expert at Arizona State University who collaborated with the two researchers years ago. “They are very, very bright guys and free spirits.”

Photographer: Ty Wright/Bloomberg

Tobacco plants in Ohio.


The antibody work came out of research projects funded more than a decade ago by the U.S. Army to develop treatments and vaccines against potential bio-warfare agents, such as the Ebola virus, Arntzen said in a telephone interview.

Tobacco Plant

The tobacco plant production system was developed because it was a method that could produce antibodies rapidly in the event of an emergency, he said.

To produce therapeutic proteins inside a tobacco plant, genes for the desired antibodies are fused to genes for a natural tobacco virus, said Arntzen. The tobacco plants are then infected with this new artificial virus, he said.

“The infection results in the production of antibodies inside the plant,” Arntzen said. The plant is eventually ground up and the antibody is extracted, he said. The whole process takes a matter of weeks.

When confronted by reporters about the Ebola infections in Liberia and subsequent treatments, Whaley said he needed to get up to speed on the developing events.

“This is all new to me,” said Whaley, who was dressed in shorts, a well-worn T-shirt and flip-flops while addressing reporters’ questions outside the company’s offices in a San Diego business park. “I just don’t want to give out any inaccurate information, that’s all.”

Antibody Cocktail

Mapp’s drug is being developed with Toronto-based Defyrus Inc., which has six employees, according to Defyrus CEO Jeff Turner. ZMapp is a “cocktail” of monoclonal antibodies that help the immune system attack the virus.

Monoclonal antibodies designed to fight and block specific proteins can stop the virus from latching onto and entering cells, said Heinz Feldmann, chief of the National Institute of Allergy and Infectious Diseases’ Laboratory of Virology in Hamilton, Montana.

The key is to find antibodies that can prevent viral infection, and to attack several points on the virus so that mutants won’t “escape” treatment, he said.

“What you want is a cocktail of antibodies that target different domains on the virus so escape is less likely in treatment,” he said in a telephone interview. Feldmann said he hasn’t been involved in developing treatments.

ZMapp’s predecessor, MB-003, protected three of seven rhesus macaques in a study run in 2013 by Mapp and the U.S. Army Medical Research Institute of Infectious Diseases.

Ethical Questions

Ebola and virology experts believe the use of the Mapp drug for Brantly and Writebol is unusual in the annals of emergency drug treatments. While potentially saving lives, the cases raise questions about who should have the right to receive experimental drugs years before they gain FDA approval.

“There are a lot of Africans that are also dying,” Robert Garry, a virologist at Tulane University, said in a telephone interview. “If we are going to do it for the Americans then we should certainly step up our game for the Africans.”

Although no drugs to treat Ebola are approved by U.S. regulators, the Food and Drug Administration can approve an emergency application to provide access to unapproved drugs, Stephanie Yao, an FDA spokeswoman, said in an e-mail.

Emergency Approval

Approval for emergency drug use outside of a clinical trial can be made within 24 hours, Yao wrote. Shipment and treatment with the drug could begin even before completed written forms are submitted to the FDA, which can approve the use of an experimental treatment by telephone in an emergency.

“The FDA stands ready to work with companies and investigators treating these patients who are in dire need of treatment,” Yao said. She declined to say whether the FDA had allowed any drug to be used in the Ebola outbreak.

Erica Ollmann Saphire, a molecular biologist at the Scripps Research Institute in San Diego, worked with Mapp and the other biotechnology companies to develop models of the Ebola virus and potential antibodies.

She directs a global consortium given the job of modeling the virus and the mixture of antibodies needed to defeat it. She said the drug was approved for the two American medical workers in Liberia under a compassionate-use doctrine, because it’s not even scheduled for clinical trials until next year.

Informed Consent

“I’d take it myself,” she said in an interview in her laboratory, near La Jolla. “Absolutely. I wouldn’t think twice.”

She said the American medical aid workers were in a better position to give consent to the treatment than African disease victims.

“Do you put an untested therapy in a human or do you just watch them die?” Saphire asked. “Certainly these two Americans are medically trained individuals who knew what they were getting into. They are able to give informed consent.”

Medical care of the two U.S. citizens may take two to three weeks if all goes well, Bruce Ribner, an infectious disease specialist at Emory, said in an Aug. 1 news conference.

The Atlanta-based Centers for Disease Control and Prevention, which confirmed that Brantly and Writebol are the first Ebola patients on U.S. soil, is working with the hospital and transport company to make sure evacuation of the two patients goes safely, said Barbara Reynolds, an agency spokeswoman.

“We’re here to make sure the transportation process and the care here in the U.S. ensures there’s no spread,” Reynolds said. “It’s important to remember this is not an airborne virus, it requires close contact with body fluids. It’s minimal risk as long as the people caring for the patient use meticulous procedures.”

To contact the reporters on this story: Robert Langreth in New York at rlangreth@bloomberg.net; Caroline Chen in New York at cchen509@bloomberg.net; John Lauerman in Boston at jlauerman@bloomberg.net

To contact the editors responsible for this story: Rick Schine at eschine@bloomberg.net Andrew Pollack

Views: 835

Reply to This

Replies to This Discussion

The tobacco plant production system was developed because it was a method that could produce rapidly in the event of an emergency, he said.

To produce therapeutic proteins inside a tobacco plant, genes for the desired antibodies are fused to genes for a natural tobacco virus, said Arntzen. The tobacco plants are then infected with this new artificial virus, he said.

This is such a tiny company it would be extremely easy for the evil Global Elites to buy up this company and hide the tobacco-cure product forcing everyone into Monsanto's Ebola Vaccination!

The following is my opinion and will therefore not include any links.

1) Research companies having gotten patents for a weakened Ebola virus for research in vaccines,

2) At least two cases now in hospitals in the US to be possibly infected with Ebola

3) US Gov. bringing back two victims with Ebola to the the US

4) The Gov. history actions and statements made regarding the Saars Pandemic, the Bird Flu Pandemic, the two or three H1N1 Pandemics,

All lead me to believe that one of the larger pharmaceutical companies will most likely purchase either the company that produced this potential cure outright, or will purchase the patent for the cure under the guise of being able to mass produce it where such a small company that developed it could not.  This will be followed by the "lame excuse" of the need for more testing, FDA approval prior to mass producing it in order to protect themselves from "liability".  This will effectively remove the "cure" from the market.  Having done this, you will then see an increase in the number of people supposedly infected with Ebola, causing the Gov. to mandate that everyone be vaccinated for Ebola.  In other words Ebola is nothing more than the next H1N1 scare. 

RSS

"Destroying the New World Order"

THANK YOU FOR SUPPORTING THE SITE!

mobile page

12160.info/m

12160 Administrators

 

TOP CONTENT THIS WEEK

Latest Activity

Phyllis Maka commented on Phyllis Maka's blog post UNBELIEVABLE HOW THEY CLONED THIS DEAD THING BACK TO LIFE/ How These Lying Pricks CHEAT US OUT OF OUR LIVING EARTH like hell they will NOT !!
"Like I said obliterate Washington DC (military) from this earth the rest will fall over, that being…"
3 hours ago
Rufus commented on guest_blog's page BBC: ‘We were wrong to hide commentator’s pro-Israeli credentials during Gaza assault’
"The BBC being less than honest?  What is the world coming to when we can't even trust our…"
3 hours ago
Mrs. Tif Morgan's 2 discussions were featured
3 hours ago
Profile IconRufus and Nigel joined truth's group
3 hours ago
Phyllis Maka's blog post was featured

NEW DRONE VIDEO FROM PEDO ISLAND - Jim Stone

"Rusty Shackleford" is at it again, and just nailed new evidence that strongly supports the…See More
3 hours ago
Mrs. Tif Morgan replied to Mrs. Tif Morgan's discussion Jeffrey Epstein Was Given Three 12 Yr Old Girls to Abuse As A Birthday Gift, Unsealed Court Documents Claim
" Now let me tell you what I know, this here, 卐, was found in Israel, it is over 12000 year…"
3 hours ago
Rufus favorited Central Scrutinizer's group Agnostic & Atheist Patriots
3 hours ago
Rufus posted a status
"Been away for 7 years! I wonder what has changed in here? In the real world, its just more of the same bs!"
4 hours ago
Rufus commented on Phyllis Maka's blog post UNBELIEVABLE HOW THEY CLONED THIS DEAD THING BACK TO LIFE/ How These Lying Pricks CHEAT US OUT OF OUR LIVING EARTH like hell they will NOT !!
"Washington DC, Vatican City, City of London - the whole lot need removing.  There is no point…"
4 hours ago
Phyllis Maka posted blog posts
5 hours ago
oldranger_68 added 3 discussions to the group Agnostic & Atheist Patriots
6 hours ago
Mrs. Tif Morgan posted discussions
7 hours ago
Burbia replied to Mrs. Tif Morgan's discussion Jeffrey Epstein Was Given Three 12 Yr Old Girls to Abuse As A Birthday Gift, Unsealed Court Documents Claim
7 hours ago
Mrs. Tif Morgan replied to Mrs. Tif Morgan's discussion I Am Becoming Soph: Boy Has This Little Girls Pissed Off The Media...:)
"We have all of her video..:)"
7 hours ago
Mrs. Tif Morgan replied to Chris of the family Masters's discussion New Zealand heads into monetary madness to save banks
"Best of luck on this issue....New Zealander's need to follow suit with the French and burn the…"
9 hours ago
Mrs. Tif Morgan replied to Mrs. Tif Morgan's discussion Central Bankers Warn of Chaos in a Cashless Society: by Laurens Cerulus and Cat Contigugli
"I have a better idea, Burn the banks to the ground, reclaim our independence from the Khazar. Do…"
9 hours ago

© 2019   Created by truth.   Powered by

Badges  |  Report an Issue  |  Terms of Service

content and site copyright 12160.info 2007-2019 - all rights reserved. unless otherwise noted